Quarterly report pursuant to Section 13 or 15(d)

Business (Details)

v3.24.3
Business (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 28, 2024
Nov. 06, 2024
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Debt Instrument [Line Items]                
Net income (loss)     $ 23,037   $ (5,228) $ 210 $ (23,376)  
Net cash used in operating activities           34,012 27,914  
Cash and cash equivalents     81,858   $ 10,180 81,858 10,180 $ 7,415
Proceeds from sale of shares pursuant to common stock private placement, net           115,625 $ 0  
Private Placement                
Debt Instrument [Line Items]                
Proceeds from sale of shares pursuant to common stock private placement, net $ 108,100     $ 108,100        
Proceeds from warrant exercises 69,400              
Private Placement | Preferred Stock                
Debt Instrument [Line Items]                
Net proceeds $ 115,600     $ 115,600        
Private Placement | Warrant liability                
Debt Instrument [Line Items]                
Fair value of warrant     $ 69,400     $ 69,400    
Sale of stock (in shares) 11,967,526              
Private Placement | Warrant liability | Subsequent Event                
Debt Instrument [Line Items]                
Proceeds from warrant exercises   $ 58,100